Log In
BCIQ
Print this Print this
 

Integrin beta(2) (LFA-1) (MAC-1) (CD18)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Integrin beta(2) (LFA-1) (MAC-1) (CD18)

BCIQ
Print ChartPrint this
1 - Ophthalmic 1 - Inflammation 1 - Dermatology
Phase of DevelopmentPreclinicalPhase IMarketed
Dermatology

1

-

-

Inflammation

-

1

-

Ophthalmic

-

-

1




 Products Targeting Integrin beta(2) (LFA-1) (MAC-1) (CD18)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$160.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/17/2013

Undisclosed

$160.0M

Undisclosed

Get a free BioCentury Trial today